Iatrogenic autoimmune progesterone dermatitis caused by 17α-hydroxyprogesterone caproate for preterm labor prevention

Cutis

Volumn 88, Issue 5, 2011, Pages 241-243

  Bandino, Justin P ^a   Thoppil, John ^b   Scott Kennedy, J ^c   Hivnor, Chad M ^a  

^a SAN ANTONIO MILITARY MEDICAL CENTER   (United States)

^b Scott and White Healthcare Center Round Rock Campus ^*  (United States)

^c Malcolm Grow Medical Center ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

17-ALPHA-HYDROXY-PROGESTERONE CAPROATE; GESTAGEN; HYDROXYPROGESTERONE CAPROATE; PROGESTERONE; PROGESTERONE DERIVATIVE;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; CASE REPORT; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; IATROGENIC DISEASE; PREGNANCY; PREMATURE LABOR;

ADULT; AUTOIMMUNE DISEASES; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; HYDROXYPROGESTERONES; IATROGENIC DISEASE; OBSTETRIC LABOR, PREMATURE; PREGNANCY; PROGESTERONE; PROGESTINS;

EID: 84857778279     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Martin JA, Hamilton BE, Sutton PD, et al. Births: final data for 2003. Natl Vital Stat Rep. 2005;54:1-116.
2. Martin JA, Hamilton BE, Sutton PD, et al. Births: final data for 2005. Natl Vital Stat Rep. 2007;56:1-103.
3. Meis PJ, Klebanoff M, Thom E, et al; National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med. 2003;348:2379-2385.
4. Goldstein P, Berrier J, Rosen S, et al. A meta-analysis of randomized control trials of progestational agents in pregnancy. Br J Obstet Gynaecol. 1989;96:265-274.
5. Society for Maternal Fetal Medicine Publications Committee. ACOG Committee Opinion number 419 October 2008 (replaces no. 291, November 2003). Use of progesterone to reduce preterm birth. Obstet Gynecol. 2008;112:963-965.
6. Tita AT, Rouse DJ. Progesterone for preterm birth prevention: an evolving intervention. Am J Obstet Gynecol. 2009;200:219-224.
7. Rittenberg C, Newman RB, Istwan NB, et al. Preterm birth prevention by 17 alpha-hydroxyprogesterone caproate vs daily nursing surveillance. J Reprod Med. 2009;54:47-52.
8. Caritis SN, Rouse DJ, Peaceman AM, et al. Prevention of preterm birth in triplets using 17 alpha-hydroxyprogesterone caproate: a randomized controlled trial. Obstet Gynecol. 2009;113(2, pt 1):285-292.
9. Kasperska-Zajac A, Brzoza Z, Rogala B. Sex hormones and urticaria [published online ahead of print May 16, 2008]. J Dermatol Sci. 2008;52:79-86.
10. Herzberg AJ, Strohmeyer CR, Cirillo-Hyland VA. Autoimmune progesterone dermatitis. J Am Acad Dermatol. 1995;32(2, pt 2):333-338.
11. Wilkinson SM, Beck MH, Kingston TP. Progesterone-induced urticaria-need it be autoimmune? Br J Dermatol. 1995;133:792-794.
12. Chawla SV, Quirk C, Sondheimer SJ, et al. Autoimmune progesterone dermatitis. Arch Dermatol. 2009;145:341-342.
13. Synder JL, Krishnaswamy G. Autoimmune progesterone dermatitis and its manifestation as anaphylaxis: a case report and literature review. Ann Allergy Asthma Immunol. 2003;90:469-477.
14. Wintzen M, Goor-van Egmond MB, Noz KC. Autoimmune progesterone dermatitis presenting with purpura and petechiae. Clin Exp Dermatol. 2004;29:316.
15. Mor Z, Caspi E. Cutaneous complications of hormonal replacement therapy. Clin Dermatol. 1997;15:147-154.
16. Pereira A, Coker A. Hypersensitivity to Mirena-a rare complication. J Obstet Gynaecol. 2003;23:81.
17. Jenkins J, Geng A, Robinson-Bostom L. Autoimmune progesterone dermatitis associated with infertility treatment. J Am Acad Dermatol. 2008;58:353-355.
18. Moody BR, Schatten S. Autoimmune progesterone dermatitis: onset in a women without previous exogenous progesterone exposure. South Med J. 1997;90:845-846.
19. Oskay T, Kutluay L, Kaptanǒ glu A, et al. Autoimmune progesterone dermatitis. Eur J Dermatol. 2002;12:589-591.
20. Kakarla N, Zurawin RK. A case of autoimmune progesterone dermatitis in an adolescent female. J Pediatr Adolesc Gynecol. 2006;19:125-129.
21. O'Rourke J, Khawaja N, Loughrey J, et al. Autoimmune progesterone dermatitis in a parturient for emergency caesarean section. Int J Obstet Anesth. 2004;13:275-278.
22. Baptist AP, Baldwin JL. Autoimmune progesterone dermatitis in a patient with endometriosis: case report and review of the literature. Clin Mol Allergy. 2004;2:10.
23. Németh H, Kovács E, Gödény S, et al. Autoimmune progesterone dermatitis diagnosed by intravaginal progesterone provocation in a hysterectomised woman. Gynecol Endocrinol. 2009;25:410-112.
24. Walling HW, Scupham RK. Autoimmune progesterone dermatitis. case report with histologic overlap of erythema multiforme and urticaria. Int J Dermatol. 2008;47:380-382.
25. Stranahan D, Rausch D, Deng A, et al. The role of intradermal skin testing and patch testing in the diagnosis of autoimmune progesterone dermatitis. Dermatitis. 2006;17:39-42.
26. Cristaudo A, Bordignon V, Palamara F, et al. Progesterone sensitive Interferon-gamma producing cells detected by ELISpot assay in autoimmune progesterone dermatitis [published online ahead of print March 14, 2007]. Clin Exp Dermatol. 2007;32:439-441.